# Rhubarb Constipation Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/rhubarb-constipation-randomized-trial-evidence-review
Category: evidence-review
Summary: Rhubarb Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are m
Last reviewed: 2026-07-27
Reviewed by: Migaku Evidence Review
# Rhubarb Constipation Randomized Trial: What the Evidence Says

## Quick Answer

Rhubarb Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Rhubarb as a Potential Component of an Anti-Inflammatory Diet | narrative review | 3 | 2025-12-09 | 10.3390/foods14244219 |
| Rhubarb enhances gastrointestinal motility via calcium-mediated intestinal acetylcholine release: a network pharmacology study | research article | 4 | 2026-02-13 | 10.1038/s41598-026-39372-z |

## What The Sources Report

- The etiology of not only physical but also mental disorders that dominate current morbidity and mortality worldwide is associated with chronic inflammation. [Kolodziejczyk-Czepas Joanna (2025); evidence level 3]
- According to the literature, more than 50% of all deaths in Western civilization are related to inflammation-associated diseases such as cardiovascular diseases, diabetes mellitus, cancer, non-alcoholic fatty liver disease (NAFLD), autoimmune diseases, and chronic kidney disease, as well as neurodegenerative disorders. [Kolodziejczyk-Czepas Joanna (2025); evidence level 3]
- Severe acute pancreatitis (SAP) can result in respiratory, circulatory, or renal organ failure persisting for more than 48 h. [Wen Zhiyong (2026); evidence level 4]
- + 12 13 14 2+ In the context of gastrointestinal motility, the electrical activity of smooth muscle cells within the digestive tract is currently understood to be associated with intracellular Catransport. [Wen Zhiyong (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For rhubarb constipation randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Kolodziejczyk-Czepas Joanna (2025). Rhubarb as a Potential Component of an Anti-Inflammatory Diet. DOI: 10.3390/foods14244219. PMCID: PMC12732050. PMID: 41464926. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12732050/
- Wen Zhiyong (2026). Rhubarb enhances gastrointestinal motility via calcium-mediated intestinal acetylcholine release: a network pharmacology study. DOI: 10.1038/s41598-026-39372-z. PMCID: PMC12982759. PMID: 41688541. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12982759/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.